We breathe life into data

Our partnership with Komodo Health enables us to better support community-based healthcare providers who serve families in the greatest need.

Komodo Health has really helped to focus people in the right area, and that’s been a huge boost for our organization.

With Komodo Health we accomplished in just a few weeks what would have taken months with consultants – extremely important as we prepare for a launch. Their software is fast, user-friendly, and delivers everything we need. It continues to be a key part of our strategy.

With Aperture, we can learn everything we need about providers in specific territories. We're getting incredible value as it quickly summarizes a lot of information that previously required a great deal of time to gather.

Aperture is the only tool I’ve used that truly helps me focus my efforts where they will make the most impact. I can now better reach the right HCPs at the right time.

Aperture gives us a better view of clinician influence than we’ve ever had. It will play a key role for all of our brands moving forward.

With Iris, we saw 30% more disease burden than we did before. We were able to add 250 new accounts and deepen our engagement by 20%.

I’d never launch a product without Iris again. It provides the most complete view of clinical encounters and enables us to precisely target the right HCPs and patients for our therapy.

Since we started using Iris, we’ve been able to more accurately align our sales force to the right territories. It’s been a game-changer.

We were way behind recruiting patients for a critical clinical trial. Within 100 days of launching Pulse, we identified and screened enough patients. After that initial delay, the trial is now on track to close early.

Pulse clinical alerts have revolutionized our way of doing business. We have relevant, accurate information at the precise moment we need it for our conversations with providers.

We needed to target specific patients who had received multiple lines of therapy. Pulse alerts enabled us to focus on high-value HCPs likely to make an upcoming treatment decision and significantly improved our success rate.

Prism enables us to conduct more accurate studies. We can now see the true outcomes of patients over time and know how effective treatments were.

Prism has become a key part of our R&D strategy. We now have access to current, detailed patient-level information to help us prioritize our funding.

The insights we get from the data in Prism has enabled us to make better decisions. We can now run reliable analyses on everything we need, from treatment decisions and outcomes to geography.

Our clients are thrilled that we can finally measure the real impact of our campaigns. The power of Sentinel to help us accurately predict true ROI is beyond anything else I’ve seen on the market.

Sentinel seamlessly integrates with our in-house tools to give us the best analytics possible. Now we can get better insights more quickly.

The road to value-based care hasn’t been an easy one, but Sentinel has enabled us to make huge progress. Now we can better understand where we can take more risks and still meet the myriad of reimbursement models.